Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE

Mid Cap | Pharmaceuticals & Drugs

927.15

-19.95 (-2.11%)

< Home < Back

Zydus Lifesciences Ltd. News

>>

Zydus Lifesciences’ venture capital arm invests in Illexcor Therapeutics

>>

Zydus Lifesciences gets USFDA’s final approval for Methenamine Hippurate Tablets

>>

Zydus Lifesciences informs about investor presentation

>>

Zydus Lifesciences gets USFDA’s final approval for Ketoconazole Shampoo

>>

Zydus Lifesciences informs about press release

>>

Zydus Lifesciences soars on getting final nod to manufacture Dasatinib Tablets

>>

Zydus Lifesciences gets final nod to manufacture Dasatinib Tablets

>>

Zydus Lifesciences rises on launching ANVIMO for transplant patients

>>

Zydus Lifesciences launches ANVIMO for transplant patients

>>

Zydus Lifesciences informs about press release

<< < 16 17 18 ...168 > >>